Literature DB >> 18490107

Neurexin 1alpha structural variants associated with autism.

Jin Yan1, Katie Noltner, Jinong Feng, Wenyan Li, Richard Schroer, Cindy Skinner, Wenqi Zeng, Charles E Schwartz, Steve S Sommer.   

Abstract

Neurexins are presynaptic membrane cell-adhesion molecules which bind to neuroligins, a family of proteins that are associated with autism. To explore the possibility that structural variants in the neurexin alpha genes predispose to autism, the coding regions and associated splice junctions of the neurexin 1alpha gene were sequenced in 116 Caucasian patients with autism and 192 Caucasian controls. Five ultra-rare structural variants including a predicted splicing mutation were found in patients with autism and absent in 10,000 control alleles. Only one ultra-rare structural variant was found in controls (5/116 vs. 1/192; P=0.03, Fisher's exact test, one-sided). In the context of all available data, the ultra-rare structural variants of the neurexin 1alpha gene are consistent with mutations predisposing to autism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490107     DOI: 10.1016/j.neulet.2008.04.074

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  71 in total

1.  PICK1 mediates synaptic recruitment of AMPA receptors at neurexin-induced postsynaptic sites.

Authors:  Junyu Xu; Chuen Kam; Jian-Hong Luo; Jun Xia
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 3.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

4.  Structural insights into the exquisite selectivity of neurexin/neuroligin synaptic interactions.

Authors:  Philippe Leone; Davide Comoletti; Géraldine Ferracci; Sandrine Conrod; Simon U Garcia; Palmer Taylor; Yves Bourne; Pascale Marchot
Journal:  EMBO J       Date:  2010-06-11       Impact factor: 11.598

5.  Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.

Authors:  Julie Gauthier; Tabrez J Siddiqui; Peng Huashan; Daisaku Yokomaku; Fadi F Hamdan; Nathalie Champagne; Mathieu Lapointe; Dan Spiegelman; Anne Noreau; Ronald G Lafrenière; Ferid Fathalli; Ridha Joober; Marie-Odile Krebs; Lynn E DeLisi; Laurent Mottron; Eric Fombonne; Jacques L Michaud; Pierre Drapeau; Salvatore Carbonetto; Ann Marie Craig; Guy A Rouleau
Journal:  Hum Genet       Date:  2011-03-22       Impact factor: 4.132

Review 6.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

7.  An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.

Authors:  Mark R Etherton; Katsuhiko Tabuchi; Manu Sharma; Jaewon Ko; Thomas C Südhof
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

8.  Rare NRXN1 promoter variants in patients with schizophrenia.

Authors:  Abhishek K Shah; Nina M Tioleco; Karen Nolan; Joseph Locker; Katherine Groh; Catalina Villa; Pavla Stopkova; Erika Pedrosa; Herbert M Lachman
Journal:  Neurosci Lett       Date:  2010-03-25       Impact factor: 3.046

9.  Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.

Authors:  Darja Kanduc
Journal:  Biologics       Date:  2010-09-13

10.  The role of rare structural variants in the genetics of autism spectrum disorders.

Authors:  M Kusenda; J Sebat
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.